Literature DB >> 6988459

Evidence for presence of insulin receptors in rat islets of Langerhans.

E J Verspohl, H P Ammon.   

Abstract

Binding of insulin to islets of Langerhans was studied. It was found that "specific" binding of [125I]insulin ("specific" binding equals total binding minus nonspecific binding) was saturable with respect to time and insulin concentration and depended on the number of incubated islets. Furthermore, bound insulin was displaced by native insulin in a dose-dependent manner. Bound [125I]insulin was easily dissociated and there was little [125I]insulin degradation both in the incubation medium and during the processes of binding and dissociation. Scatchard analysis of experiments with increasing [125I]insulin concentration and with displacement of insulin binding by native insulin revealed "high affinity" binding sites with a dissociation constant of 0.461 +/- 0.08 n M and 3.5 X 10(6) high affinity binding sites per islet. There also existed "low affinity" binding sites with dissociation constant (Kd) of 43.9 +/- 11.6 nM and 5.9 X 10(7) low affinity binding sites. High affinity binding sites of islets from rats pretreated with alloxan decreased by about one half, whereas Kd was unaffected. Because the Kd of specific high affinity binding and mean effective dose (ED50) of the biological effects of insulin on normal pancreatic islets are in the same range (between 0.46 and 1.19 nM), the insulin-receptor interaction may be biologically significant.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6988459      PMCID: PMC371457          DOI: 10.1172/JCI109778

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Insulin action in isolated rat thymocytes. I. Binding of 125 I-insulin and stimulation of -aminoisobutyric acid transport.

Authors:  I D Goldfine; J D Gardner; D M Neville
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

2.  Insulin-receptor interactions in liver cell membranes.

Authors:  P Cuatrecasas; B Desbuquois; F Krug
Journal:  Biochem Biophys Res Commun       Date:  1971-07-16       Impact factor: 3.575

3.  Binding and degradation of 125I-labelled insulin by isolated rat fat cells.

Authors:  S Gammeltoft; J Gliemann
Journal:  Biochim Biophys Acta       Date:  1973-08-17

4.  Heterogeneity of insulin receptors on fat cell membranes.

Authors:  J M Hammond; L Jarett; I K Mariz; W H Daughaday
Journal:  Biochem Biophys Res Commun       Date:  1972-11-15       Impact factor: 3.575

5.  Properties of the insulin receptor of isolated fat cell membranes.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1971-12-10       Impact factor: 5.157

6.  Method for the isolation of intact islets of Langerhans from the rat pancreas.

Authors:  P E Lacy; M Kostianovsky
Journal:  Diabetes       Date:  1967-01       Impact factor: 9.461

7.  Evidence for a feedback inhibition of insulin on insulin secretion in the isolated, perfused canine pancreas.

Authors:  J Iversen; D W Miles
Journal:  Diabetes       Date:  1971-01       Impact factor: 9.461

8.  Adenylate cyclase in islets of Langerhans. Isolation of islets and regulation of adenylate cyclase activity by various hormones and agents.

Authors:  W N Kuo; D S Hodgins; J F Kuo
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

9.  6-Amnionicotinamide (6-AN) as a diabetogenic agent. In vitro and in vivo studies in the rat.

Authors:  H P Ammon; J Steinke
Journal:  Diabetes       Date:  1972-03       Impact factor: 9.461

10.  Insulin--receptor interactions in adipose tissue cells: direct measurement and properties.

Authors:  P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

View more
  12 in total

1.  Binding and internalization of somatostatin, insulin, and glucagon by cultured rat islet cells.

Authors:  M Amherdt; Y C Patel; L Orci
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

Review 2.  Islet cell interactions with pancreatic B-cells.

Authors:  D Pipeleers
Journal:  Experientia       Date:  1984-10-15

3.  Identification of functional insulin receptors on membranes from an insulin-producing cell line (RINm5F).

Authors:  H Gazzano; P Halban; M Prentki; R Ballotti; D Brandenburg; M Fehlmann; E Van Obberghen
Journal:  Biochem J       Date:  1985-03-15       Impact factor: 3.857

4.  Modulation of JNK and p38 stress activated protein kinases in isolated islets of Langerhans: insulin as an autocrine survival signal.

Authors:  S Paraskevas; R Aikin; D Maysinger; J R Lakey; T J Cavanagh; D Agapitos; R Wang; L Rosenberg
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

5.  Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro.

Authors:  E J Verspohl; G Wunderle; H P Ammon; J A Williams; I D Goldfine
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-03       Impact factor: 3.000

6.  Anti-insulin antiserum increases inositol phosphate accumulation in rat pancreatic islets.

Authors:  E J Verspohl; H P Ammon; M Klosa
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

7.  Atrial natriuretic peptide (ANP) acts via specific binding sites on cGMP system of rat pancreatic islets without affecting insulin release.

Authors:  E J Verspohl; H P Ammon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

8.  Insulin inhibits its own secretion from isolated, perifused human pancreatic islets.

Authors:  P Marchetti; D W Scharp; M McLear; E H Finke; B Olack; C Swanson; R Giannarelli; R Navalesi; P E Lacy
Journal:  Acta Diabetol       Date:  1995-06       Impact factor: 4.280

9.  Cholecystokinin (CCK8) regulates glucagon, insulin, and somatostatin secretion from isolated rat pancreatic islets: interaction with glucose.

Authors:  E J Verspohl; H P Ammon
Journal:  Pflugers Arch       Date:  1987-10       Impact factor: 3.657

10.  In vitro effect of exogenous insulin on insulin secretion. Studies with glucose, leucine, arginine, aminophylline and tolbutamide.

Authors:  E J Verspohl; M Händel; I Hagenloh; H P Ammon
Journal:  Acta Diabetol Lat       Date:  1982 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.